{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:18:17Z","timestamp":1787163497545,"version":"build-2736575974"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T00:00:00Z","timestamp":1653350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T00:00:00Z","timestamp":1653350400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100007427","name":"Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences","doi-asserted-by":"publisher","award":["22198-1"],"award-info":[{"award-number":["22198-1"]}],"id":[{"id":"10.13039\/501100007427","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-022-01823-5","type":"journal-article","created":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T13:40:55Z","timestamp":1653399655000},"page":"1919-1924","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Treatment of post-radioactive iodine relapse of hyperthyroidism: comparison of long-term methimazole and radioactive iodine treatment"],"prefix":"10.1007","volume":"45","author":[{"given":"N.","family":"Saadat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Azizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Abdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1046-0003","authenticated-orcid":false,"given":"A.","family":"Amouzegar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,24]]},"reference":[{"issue":"10","key":"1823_CR1","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1089\/thy.2016.0229","volume":"26","author":"DS Ross","year":"2016","unstructured":"Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL et al (2016) 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid 26(10):1343\u20131421","journal-title":"Thyroid"},{"issue":"4","key":"1823_CR2","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/000490384","volume":"7","author":"GJ Kahaly","year":"2018","unstructured":"Kahaly GJ, Bartalena L, Heged\u00fcs L, Leenhardt L, Poppe K, Pearce SH (2018) 2018 European Thyroid Association guideline for the management of Graves\u2019 hyperthyroidism. European Thyroid J 7(4):167\u2013186","journal-title":"European Thyroid J"},{"issue":"02\/03","key":"1823_CR3","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1055\/s-0029-1211072","volume":"97","author":"L Wartofsky","year":"1991","unstructured":"Wartofsky L, Glinoer D, Solomon B, Lagasse R (1991) Differences and similarities in the treatment of diffuse goiter in Europe and the United States. Exp Clin Endocrinol Diabetes 97(02\/03):243\u2013251","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"3","key":"1823_CR4","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1089\/thy.2019.0132","volume":"30","author":"JP Brito","year":"2020","unstructured":"Brito JP, Payne S, Singh Ospina N, Rodriguez-Gutierrez R, Maraka S, Sangaralingham LR et al (2020) Patterns of use, efficacy, and safety of treatment options for patients with Graves\u2019 disease: a nationwide population-based study. Thyroid 30(3):357\u2013364","journal-title":"Thyroid"},{"issue":"2","key":"1823_CR5","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.ecl.2009.01.009","volume":"38","author":"L Heged\u00fcs","year":"2009","unstructured":"Heged\u00fcs L (2009) Treatment of Graves\u2019 hyperthyroidism: evidence-based and emerging modalities. Endocrinol Metab Clin N Am 38(2):355\u2013371","journal-title":"Endocrinol Metab Clin N Am"},{"key":"1823_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40618-021-01601-9","volume":"45","author":"F Azizi","year":"2022","unstructured":"Azizi F, Abdi H, Mehran L, Amouzegar A (2022) Appropriate duration of antithyroid drug treatment as a predictor for relapse of Graves\u2019 disease: a systematic scoping review. J Endocrinol Investig 45:1\u201312","journal-title":"J Endocrinol Investig"},{"issue":"10","key":"1823_CR7","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1089\/thy.2016.0652","volume":"27","author":"F Azizi","year":"2017","unstructured":"Azizi F, Malboosbaf R (2017) Long-term antithyroid drug treatment: a systematic review and meta-analysis. Thyroid 27(10):1223\u20131231","journal-title":"Thyroid"},{"key":"1823_CR8","unstructured":"Azizi F, Yousefi V, Bahrainian A, Sheikholeslami F, Tohidi M, Mehrabi Y (2012) Long-term continuous methimazole or radioiodine treatment for hyperthyroidism. Arch Iranian Med 15(8)"},{"issue":"12","key":"1823_CR9","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1089\/thy.2015.0195","volume":"25","author":"D Villagelin","year":"2015","unstructured":"Villagelin D, Romaldini JH, Santos RB, Milkos AB, Ward LS (2015) Outcomes in relapsed Graves\u2019 disease patients following radioiodine or prolonged low dose of methimazole treatment. Thyroid 25(12):1282\u20131290","journal-title":"Thyroid"},{"issue":"9","key":"1823_CR10","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1089\/thy.2019.0180","volume":"29","author":"F Azizi","year":"2019","unstructured":"Azizi F, Amouzegar A, Tohidi M, Hedayati M, Khalili D, Cheraghi L et al (2019) Increased remission rates after long-term methimazole therapy in patients with Graves\u2019 disease: results of a randomized clinical trial. Thyroid 29(9):1192\u20131200","journal-title":"Thyroid"},{"key":"1823_CR11","doi-asserted-by":"crossref","unstructured":"Malboosbaf R, Azizi F (2020) Long-term treatment with antithyroid drugs: efficacy and safety. Int J Endocrinol Metab 18(Suppl)","DOI":"10.5812\/ijem.101487"},{"issue":"1","key":"1823_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/cen.14374","volume":"95","author":"OM El Kawkgi","year":"2021","unstructured":"El Kawkgi OM, Ross DS, Stan MN (2021) Comparison of long-term antithyroid drugs versus radioactive iodine or surgery for Graves\u2019 disease: a review of the literature. Clin Endocrinol 95(1):3\u201312","journal-title":"Clin Endocrinol"},{"issue":"3","key":"1823_CR13","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1089\/thy.2018.0320","volume":"29","author":"M Lillevang-Johansen","year":"2019","unstructured":"Lillevang-Johansen M, Abrahamsen B, J\u00f8rgensen HL, Brix TH, Heged\u00fcs L (2019) Duration of hyperthyroidism and lack of sufficient treatment are associated with increased cardiovascular risk. Thyroid 29(3):332\u2013340","journal-title":"Thyroid"},{"issue":"4","key":"1823_CR14","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1089\/thy.2011.0156","volume":"22","author":"H Delshad","year":"2012","unstructured":"Delshad H, Amouzegar A, Mirmiran P, Mehran L, Azizi F (2012) Eighteen years of continuously sustained elimination of iodine deficiency in the Islamic Republic of Iran: the vitality of periodic monitoring. Thyroid 22(4):415\u2013421","journal-title":"Thyroid"},{"issue":"11","key":"1823_CR15","first-page":"950","volume":"36","author":"A Amouzegar","year":"2013","unstructured":"Amouzegar A, Delshad H, Mehran L, Tohidi M, Khafaji F, Azizi F (2013) Reference limit of thyrotropin (TSH) and free thyroxine (FT4) in thyroperoxidase positive and negative subjects: a population based study. J Endocrinol Invest 36(11):950\u2013954","journal-title":"J Endocrinol Invest"},{"issue":"5","key":"1823_CR16","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1089\/thy.2018.0397","volume":"29","author":"F Azizi","year":"2019","unstructured":"Azizi F, Takyar M, Madreseh E, Amouzegar A (2019) Treatment of toxic multinodular goiter: comparison of radioiodine and long-term methimazole treatment. Thyroid 29(5):625\u2013630","journal-title":"Thyroid"},{"issue":"5","key":"1823_CR17","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1210\/jc.2012-3459","volume":"98","author":"K Boelaert","year":"2013","unstructured":"Boelaert K, Maisonneuve P, Torlinska B, Franklyn JA (2013) Comparison of mortality in hyperthyroidism during periods of treatment with thionamides and after radioiodine. J Clin Endocrinol Metab 98(5):1869\u20131882","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1823_CR18","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1089\/thy.2012.0500","volume":"23","author":"F Brandt","year":"2013","unstructured":"Brandt F, Thvilum M, Almind D, Christensen K, Green A, Heged\u00fcs L et al (2013) Graves\u2019 disease and toxic nodular goiter are both associated with increased mortality but differ with respect to the cause of death: a Danish population-based register study. Thyroid 23(4):408\u2013413","journal-title":"Thyroid"},{"issue":"12","key":"1823_CR19","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1007\/s40618-021-01590-9","volume":"44","author":"G Corona","year":"2021","unstructured":"Corona G, Croce L, Sparano C, Petrone L, Sforza A, Maggi M et al (2021) Thyroid and heart, a clinically relevant relationship. J Endocrinol Invest 44(12):2535\u20132544","journal-title":"J Endocrinol Invest"},{"issue":"7","key":"1823_CR20","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1210\/jc.2017-00166","volume":"102","author":"M Lillevang-Johansen","year":"2017","unstructured":"Lillevang-Johansen M, Abrahamsen B, J\u00f8rgensen HL, Brix TH, Heged\u00fcs L (2017) Excess mortality in treated and untreated hyperthyroidism is related to cumulative periods of low serum TSH. J Clin Endocrinol Metab 102(7):2301\u20132309","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1823_CR21","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/S2213-8587(19)30059-2","volume":"7","author":"OE Okosieme","year":"2019","unstructured":"Okosieme OE, Taylor PN, Evans C, Thayer D, Chai A, Khan I et al (2019) Primary therapy of Graves\u2019 disease and cardiovascular morbidity and mortality: a linked-record cohort study. Lancet Diabetes Endocrinol 7(4):278\u2013287","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"1823_CR22","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1089\/ct.2019;31.185-188","volume":"31","author":"SS Ganji","year":"2019","unstructured":"Ganji SS, Cooper DS (2019) Long-term methimazole is as effective as radioiodine therapy for the treatment of toxic multinodular goiter. Clin Thyroidol 31(5):185\u2013188","journal-title":"Clin Thyroidol"},{"issue":"5","key":"1823_CR23","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1530\/eje.1.01904","volume":"152","author":"F Azizi","year":"2005","unstructured":"Azizi F, Ataie L, Hedayati M, Mehrabi Y, Sheikholeslami F (2005) Effect of long-term continuous methimazole treatment of hyperthyroidism: comparison with radioiodine. Eur J Endocrinol 152(5):695\u2013701","journal-title":"Eur J Endocrinol"},{"key":"1823_CR24","doi-asserted-by":"crossref","unstructured":"Azizi F, Amouzegar A, Tohidi M, Hedayati M, Cheraghi L, Mehrabi Y (2019) Systemic thyroid hormone status in treated Graves\u2019 disease. Int J Endocrinol Metab 17(4)","DOI":"10.5812\/ijem.95385"},{"issue":"12","key":"1823_CR25","doi-asserted-by":"publisher","first-page":"4964","DOI":"10.1210\/jc.2016-2660","volume":"101","author":"SJ Peterson","year":"2016","unstructured":"Peterson SJ, McAninch EA, Bianco AC (2016) Is a normal TSH synonymous with \u201ceuthyroidism\u201d in levothyroxine monotherapy? J Clin Endocrinol Metab 101(12):4964\u20134973","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1823_CR26","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1159\/000512734","volume":"10","author":"L Russo","year":"2021","unstructured":"Russo L, Nguyen TNH, Kyrilli A, Robin M, Lassen PB, Moreno-Reyes R et al (2021) Metabolic changes after radioiodine correction of grade 1 and grade 2 subclinical hyperthyroidism. Eur Thyroid J 10(5):382\u2013389","journal-title":"Eur Thyroid J"},{"issue":"3","key":"1823_CR27","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1089\/thy.2015.0345","volume":"26","author":"MH Samuels","year":"2016","unstructured":"Samuels MH, Kolobova I, Smeraglio A, Peters D, Purnell JQ, Schuff KG (2016) Effects of levothyroxine replacement or suppressive therapy on energy expenditure and body composition. Thyroid 26(3):347\u2013355","journal-title":"Thyroid"},{"issue":"5","key":"1823_CR28","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1046\/j.1365-2265.2002.01654.x","volume":"57","author":"P Saravanan","year":"2002","unstructured":"Saravanan P, Chau WF, Roberts N, Vedhara K, Greenwood R, Dayan CM (2002) Psychological well-being in patients on \u201cadequate\u201d doses of l-thyroxine: results of a large, controlled community-based questionnaire study. Clin Endocrinol (Oxf) 57(5):577\u2013585 (Epub 2002\/10\/23)","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-022-01823-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-022-01823-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-022-01823-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T09:55:46Z","timestamp":1662717346000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-022-01823-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,24]]},"references-count":28,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["1823"],"URL":"https:\/\/doi.org\/10.1007\/s40618-022-01823-5","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,24]]},"assertion":[{"value":"20 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None of the authors have any financial conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}